NASDAQ:NMTC NeuroOne Medical Technologies (NMTC) Stock Price, News & Analysis $0.80 0.00 (0.00%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$0.75▼$0.8350-Day Range$0.68▼$1.0952-Week Range$0.65▼$2.00Volume37,577 shsAverage Volume158,304 shsMarket Capitalization$22.38 millionP/E RatioN/ADividend YieldN/APrice Target$2.20 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get NeuroOne Medical Technologies alerts: Email Address NeuroOne Medical Technologies MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside173.7% Upside$2.20 Price TargetShort InterestHealthy0.47% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.44Based on 2 Articles This WeekInsider TradingSelling Shares$22,704 Sold Last QuarterProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.78 out of 5 starsMedical Sector462nd out of 936 stocksSurgical & Medical Instruments Industry60th out of 101 stocks 3.5 Analyst's Opinion Consensus RatingNeuroOne Medical Technologies has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageNeuroOne Medical Technologies has received no research coverage in the past 90 days.Read more about NeuroOne Medical Technologies' stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.47% of the float of NeuroOne Medical Technologies has been sold short.Short Interest Ratio / Days to CoverNeuroOne Medical Technologies has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in NeuroOne Medical Technologies has recently decreased by 44.81%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldNeuroOne Medical Technologies does not currently pay a dividend.Dividend GrowthNeuroOne Medical Technologies does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NMTC. Previous Next 3.6 News and Social Media Coverage News SentimentNeuroOne Medical Technologies has a news sentiment score of 1.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for NeuroOne Medical Technologies this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for NMTC on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat Follows3 people have added NeuroOne Medical Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Previous Next 0.8 Company Ownership Insider Buying vs. Insider SellingIn the past three months, NeuroOne Medical Technologies insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $22,704.00 in company stock.Percentage Held by InsidersOnly 7.50% of the stock of NeuroOne Medical Technologies is held by insiders.Percentage Held by InstitutionsOnly 16.07% of the stock of NeuroOne Medical Technologies is held by institutions.Read more about NeuroOne Medical Technologies' insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of NeuroOne Medical Technologies is -1.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of NeuroOne Medical Technologies is -1.39, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioNeuroOne Medical Technologies has a P/B Ratio of 3.09. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about NeuroOne Medical Technologies' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Monument Traders AllianceNEW AI developed by trader who won 1,129% (in 2 days)Earlier this year one legendary trader captured a 1,129% win (in just 2 days) ... LIVE in front of thousands of Americans...Click here to see how >>> About NeuroOne Medical Technologies Stock (NASDAQ:NMTC)NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.Read More NMTC Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NMTC Stock News HeadlinesJune 20, 2024 | globenewswire.comNeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF AblationMay 24, 2024 | morningstar.comNeuroOne Medical Technologies Corp NMTCJuly 26, 2024 | Porter & Company (Ad)Nvidia insiders dumping sharesAll the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.May 15, 2024 | msn.comNeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Q2 2024 Earnings Call TranscriptMay 15, 2024 | finanznachrichten.deNeuroOne Medical Technologies Corp: NeuroOne Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateMay 15, 2024 | finance.yahoo.comNeuroOne Medical Technologies Corp (NMTC) (Q2 2024) Earnings Call Transcript Highlights:May 14, 2024 | investorplace.comNMTC Stock Earnings: NeuroOne Medical Tech Misses EPS, Misses Revenue for Q2 2024May 14, 2024 | globenewswire.comNeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate UpdateJuly 26, 2024 | Porter & Company (Ad)Nvidia insiders dumping sharesAll the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.May 10, 2024 | globenewswire.comNeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14May 6, 2024 | finance.yahoo.comFavourable Signals For NeuroOne Medical Technologies: Numerous Insiders Acquired StockApril 11, 2024 | stockhouse.comNeuroOne® Announces First Implant of OneRF(TM) Ablation ElectrodesApril 10, 2024 | globenewswire.comNeuroOne® CEO Dave Rosa Featured on Bloomberg TechnologyApril 9, 2024 | globenewswire.comNeuroOne® Announces First Implant of OneRF™ Ablation ElectrodesApril 4, 2024 | finance.yahoo.comNeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.April 4, 2024 | globenewswire.comNeuroOne® CEO Dave Rosa Featured on Fox Business Network's Varney & Co.March 28, 2024 | stockhouse.comNeuroOne® Initiates Limited Commercial Launch of OneRF(TM) Ablation SystemMarch 26, 2024 | finance.yahoo.comNeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation SystemSee More Headlines Receive NMTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NeuroOne Medical Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today7/26/2024Next Earnings (Estimated)8/12/2024Fiscal Year End9/30/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:NMTC CUSIPN/A CIK1500198 Webwww.originalsourcemusic.com Phone(952) 426-1383FaxN/AEmployees16Year FoundedN/APrice Target and Rating Average Stock Price Target$2.20 High Stock Price Target$2.20 Low Stock Price Target$2.20 Potential Upside/Downside+178.5%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.58) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-11,860,000.00 Net Margins-343.55% Pretax Margin-343.52% Return on Equity-277.71% Return on Assets-204.28% Debt Debt-to-Equity RatioN/A Current Ratio3.06 Quick Ratio2.21 Sales & Book Value Annual Sales$1.95 million Price / Sales11.28 Cash FlowN/A Price / Cash FlowN/A Book Value$0.26 per share Price / Book3.04Miscellaneous Outstanding Shares27,840,000Free Float25,754,000Market Cap$21.99 million OptionableOptionable Beta0.69 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. David A. Rosa M.D. (Age 60)President, CEO & Director Comp: $759.98kMr. Ronald W. McClurg (Age 64)Chief Financial Officer Comp: $358.79kMr. Steven Mertens (Age 61)Chief Technology Officer Comp: $332.26kMr. Mark Christianson (Age 57)Co-Founder, Business Development Director & Medical Sales Liaison Comp: $260.85kMr. Christopher R. Volker CFAChief Operating OfficerMr. Hijaz HarisVice President of MarketingMore ExecutivesKey CompetitorsChembio DiagnosticsNASDAQ:CEMICheck-CapNASDAQ:CHEKHealth Sciences Acquisitions Co. 2NASDAQ:HSAQMonogram OrthopaedicsNASDAQ:MGRMenVVeno MedicalNASDAQ:NVNOView All CompetitorsInsidersMark ChristiansonSold 25,800 sharesTotal: $22,704.00 ($0.88/share)Mark ChristiansonSold 6,848 sharesTotal: $9,244.80 ($1.35/share)Mark ChristiansonSold 9,907 sharesTotal: $13,869.80 ($1.40/share)Christopher VolkerBought 75,000 shares on 12/21/2023Total: $105,000.00 ($1.40/share)Ronald W McclurgBought 50,900 shares on 9/13/2023Total: $49,882.00 ($0.98/share)View All Insider Transactions NMTC Stock Analysis - Frequently Asked Questions How have NMTC shares performed this year? NeuroOne Medical Technologies' stock was trading at $1.58 on January 1st, 2024. Since then, NMTC shares have decreased by 49.1% and is now trading at $0.8039. View the best growth stocks for 2024 here. How were NeuroOne Medical Technologies' earnings last quarter? NeuroOne Medical Technologies Co. (NASDAQ:NMTC) issued its earnings results on Tuesday, May, 14th. The company reported ($0.11) earnings per share for the quarter. The firm earned $1.38 million during the quarter. NeuroOne Medical Technologies had a negative net margin of 343.55% and a negative trailing twelve-month return on equity of 277.71%. How do I buy shares of NeuroOne Medical Technologies? Shares of NMTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NMTC) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroOne Medical Technologies Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroOne Medical Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NMTC Stock Alerts